Stay updated on Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-22T21:37:47.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Updated the page revision tag from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:41:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Gastric cancer was added to the conditions section and the Genetic and Rare Diseases Information Center resource was included under resources; the page revision was updated from v3.4.1 to v3.4.2.
    Difference
    0.1%
    Check dated 2026-02-15T03:16:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no observable changes to study details or listed information.
    Difference
    0.0%
    Check dated 2026-02-08T03:11:51.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata items (Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0). Removed the previous metadata entries (Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4).
    Difference
    0.1%
    Check dated 2026-01-24T22:32:07.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no user-facing study details or sections appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-18T00:39:13.000Z thumbnail image

Stay in the know with updates to Avelumab in 3rd-Line Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Avelumab in 3rd-Line Gastric Cancer Clinical Trial page.